AndhraNews.net
Home » Business News » 2011 » December » December 5, 2011

Wolters Kluwer Health Acquires Leading Open Access STM Journal Publisher in India


December 5, 2011 - Philadelphia, PA



Acquisition Gives Wolters Kluwer Health Strong Foothold in Open AccessPublishing Business

Philadelphia, Pa. (December 5, 2011) - Wolters Kluwer Health todayannouncedthat it has acquired Medknow PVT Ltd., a leading Scientific, Technical &Medical(STM) journal publishing operation headquartered in Mumbai, India and oneof thelargest open access publishers in the world. The acquisition expandsWoltersKluwer Health's Medical Research business' presence in key developingmarketsand supports its strategy to increase locally written content andincorporatemore open access platforms into its business model. Terms of the deal werenotdisclosed.

"Research is changing in the developing world with clinicians andresearcherslooking for more access to locally-written content that is peer-reviewedandaccessible via open platforms," said Karen Abramson, President & CEO,WoltersKluwer Health, Medical Research. "Our acquisition of Medknow aligns withourstrategy of continuing to invest in providing the latest, most trustedinformation to our customers around the world to help them fuel discoveriesandenhance patient care."

Founded in 1977, Medknow has a strong portfolio of more than 155 journalsandoffers much of its content electronically. The company has strong marketshareamong journals published in India and also has a growing presence in AsiaPacific and the MEA region. In addition to its print and electronic journalcontent, the company provides an electronic peer-review system for authorsandeditors, ensuring high quality clinical research. The deal will enableWoltersKluwer Health to accelerate advances in the open access arena. It alsofurthersthe company's growth strategy of continued investment in internationalexpansionin key emerging markets across the globe.

For Wolters Kluwer Health customers, the deal means expanded access tomedicalcontent in more markets around the world. Medknow's journals will join anextensive portfolio of nearly 300 practitioner journals, including thosewhichare published by Wolters Kluwer Health's Lippincott Williams & Wilkinsbrand andadditional journals made available through our society partnerships. Therewillalso be opportunities via Wolters Kluwer Health's Ovid brand, which is theonline source for the latest electronic research information used by theworld'sleading universities, academic research libraries, hospitals andpharmaceuticalcompanies, among others.

For more information on Wolters Kluwer Health, visitwww.wolterskluwerhealth.com. For more information on Medknow, visitwww.medknow.com.

About Wolters Kluwer HealthWolters Kluwer Health (Philadelphia, PA) is a leading provider ofinformationand business intelligence for students, professionals and institutions inmedicine, nursing, allied health and pharmacy. Major brands includetraditionalpublishers of medical and drug reference tools and textbooks, suchasLippincottWilliams & Wilkins and Facts & Comparisons(®); and electronicinformationproviders, such as Ovid(®), UpToDate(®), Medi-Span(®),Pharmacy OneSource andProVation(®) Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading globalinformation services company. Professionals in the areas of legal,business,tax, accounting, finance, audit, risk, compliance, and healthcare rely onWolters Kluwer's leading, information-enabled tools and solutions to managetheir business efficiently, deliver results to their clients, and succeedin anever more dynamic world.

Wolters Kluwer has 2010 annual revenues of EUR3.6 billion ($4.7 billion),employsapproximately 19,300 people worldwide, and maintains operations in over 40countries across Europe, North America, Asia Pacific, and Latin America.WoltersKluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its sharesarequoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext100indices.

Forward-looking StatementsThis press release contains forward-looking statements. These statementsmay beidentified by words such as "expect", "should", "could", "shall", andsimilarexpressions. Wolters Kluwer cautions that such forward-looking statementsarequalified by certain risks and uncertainties that could cause actualresults andevents to differ materially from what is contemplated by the forward-lookingstatements. Factors which could cause actual results to differ from theseforward-looking statements may include, without limitation, generaleconomicconditions; conditions in the markets in which Wolters Kluwer is engaged;behavior of customers, suppliers, and competitors; technologicaldevelopments;the implementation and execution of new ICT systems or outsourcing; andlegal,tax, and regulatory rules affecting Wolters Kluwer's businesses, as well asrisks related to mergers, acquisitions, and divestments. In addition,financialrisks such as currency movements, interest rate fluctuations, liquidity,andcredit risks could influence future results. The foregoing list of factorsshould not be construed as exhaustive. Wolters Kluwer disclaims anyintention orobligation to publicly update or revise any forward-looking statements,whetheras a result of new information, future events, or otherwise.

+--------+-------------------------------+----------------------------------+




PDF version of Press Release:http://hugin.info/130682/R/1569141/487718.pdf




This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:(i) the releases contained herein are protected by copyright and other applicable laws; and(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Wolters Kluwer NV via Thomson Reuters ONE

[HUG#1569141]

Contact:
Robert Dekker |
Vice President, Communications Relations|
Wolters Kluwer Health |
+1 (215) 521-8928 |
Email Contact|

Jon Teppo
Vice President, Investor
Wolters Kluwer
+ 31 (0)172 641 407
Email Contact

MarketWire

Comment on this story

Share